The Analyst Verdict: GeneDx Hldgs In The Eyes Of 6 Experts
The Analyst Verdict: GeneDx Hldgs In The Eyes Of 6 Experts
分析师的观点：GeneDx控股在6位专家眼中
The standing of GeneDx Hldgs among financial experts becomes clear with a thorough analysis...Analysts' ratings for GeneDx Hldgs (NASDAQ:WGS) over the last quarter vary from bullish to bearish, as provided by 6 analysts.
过去季度对GeneDx控股（纳斯达克：WGS）的分析师评级从看好到看淡不等，由6位分析师提供。
The following table summarizes their recent ratings, shedding light on the changing sentiments within the past 30 days and comparing them to the preceding months.
以下表格总结了分析师们最近的评级，揭示了过去30天内情绪的变化并将其与前几个月进行了比较。
The 12-month price targets, analyzed by analysts, offer insights with an average target of $43.5, a high estimate of $54.00, and a low estimate of $32.00. This current average has increased by 18.21% from the previous average price target of $36.80.
分析师分析的12个月价格目标提供了洞察，平均目标为43.5美元，最高估值为54.00美元，最低估值为32.00美元。当前平均值比之前的36.80美元的平均价格目标增加了18.21%。
Decoding Analyst Ratings: A Detailed Look
分析师评级解读：详细解析
The standing of GeneDx Hldgs among financial experts becomes clear with a thorough analysis...
通过对最近分析师行动进行彻底...
登录免费看全文
登录/注册
资讯热榜
更新时间